Tandutinib

tandutinib · Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Tandutinib, covering 2009-05-20 to 2017-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma [Phase 1, Phase 2]